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Abstract
SAPHO is an acronym for Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis. The
syndrome is difficult to diagnose because it may present many different manifestations
in adults and children. Its origin is still unknown, although some infectious, genetic
and immune hypotheses have been put forward. We report the case of a 49-year-old
woman with SAPHO syndrome, who developed a serious cutaneous allergy following
the insertion of a removable partial denture (RPD). The oral care and treatment of this
patient are described.
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1 INTRODUCTION
SAPHO syndrome (SAPHO is an acronym for Synovi-
tis, Acne, Pustulosis, Hyperostosis, Osteitis) is a poorly
known disease, classified as rare with a prevalence close to
1/10 000.1–3 It was long considered as a spondylarthrosis
because of the spinal manifestations but the association with
other symptoms led to a distinction being made between the
two diseases.4
It was first reported in the late 1980s by Chamot et al
who defined some diagnosis criteria for this syndrome at the
time.5–7 The syndrome brings together inflammatory osteitis,
osteoarticular features, hyperostosis, and skin manifestations
such as severe acne or palmoplantar pustulosis.1,8 Peripheral
arthritis and synovitis are also noted in a third of patients8
and, in others, cutaneous reactions can resemble. It is often
noted that skin features occur before osseous ones but there
are strong variations among patients and skin manifestations
can also appear later in the evolution of the syndrome.9 Back
pain and anterior chest wall (sternum, clavicle, sternocosto-
clavicular) involvement5,8,10 are typical early presentations1
and considered main diagnostic criteria and distinguished
from other types of pathologies (osteitis, spondyloarthritis, or
osteoslerotic metastases of breast cancers).9–11 Differential
diagnosis is complicated by the multiplicity of symptoms
and the strong variations in their occurrence.1,8,12 All of
these symptoms of chronic intense pain can affect the
patient's quality of life13 and are associated with a 7.5% risk
of depressive episodes.14 Osseous manifestations explain
why scintillography and magnetic resonance imaging are
commonly used to establish or confirm the diagnosis.15–17
The general management of SAPHO syndrome is empirical
and the long-term prognosis has not been established.14 Bis-
phosphonates are commonly used against osteomyelitis and
osteitis18,19 but they are not efficient in every case and many
reports have been published on other treatments attempted
in the absence of response to bisphosphonates, such as anti-
IL1, Janus kinase inhibitor or, recently, TNF blockers.1,12,20,21
However, no therapy has demonstrated an effect in all patients
and remission may be only partial, with disappearance of skin
symptoms but persistence of bone lesions.21
Oral manifestations of SAPHO syndrome predominantly
concern mandibular osteomyelitis22–27 but some necrosis may
also occur due to dental surgery in concomitance with the
administration of bisphosphonate treatments. However, the
mandible is affected by osseous manifestations in only 10%
F I G U R E 1 Panoramic radiograph performed during patient's
first visit to the dental unit
of cases,8,22 that is, less often than the anterior chest wall or
spine.1
In this context, the aim of this case report is to describe the
oral care of a SAPHO patient who suffered a sudden allergy
after the insertion of a metal removable partial denture (RPD).
2 CASE REPORT
A 49-year-old woman with SAPHO syndrome came to the
dental unit of Toulouse Hospital because of acute dental pain
and for aesthetic considerations. Because of her long dental
history, she “wanted “to have all her teeth extracted.” At this
time, she had never had a RPD and never reported any allergy.
Her SAPHO syndrome had been discovered some years
previously after a work-related accident when she was work-
ing as a nurse. She experienced severe pain on attempting to
lift a patient and therefore underwent a medical examination
including radiography. The diagnosis was based on the full
body and long bone radiographs and the concomitant severe
back and articular pain. During the first consultation in
the dental unit, a medical check-up revealed osteoarticular
degeneration, peripheral arthritis and massive cutaneous
involvements. The patient was not treated with bispho-
sphonates but only with anti-inflammatory (Ketoprofen),
antalgic (Tramadol, Gabapentin), and psychotropic medicines
(Hydroxyzine, Zopiclone). Ketoprofen is commonly used
for the symptomatic long-term treatment of chronic inflam-
matory rheumatism, and Gabapentin may be prescribed not
only for its analgesic properties but also its propensity to
reduce epileptic and spasmodic seizures. During an oral
examination, generalized chronic periodontitis was observed
with mobilities and bleeding on probing. A panoramic
radiograph confirmed the diminution of the alveolar bone
level and the presence of foci of infection, especially on teeth
47 and 48 (Figure 1). The radiograph showed no evidence of
osteoarticular degeneration in the jaws and is consistent with
the low incidence in the reported in the literature.22
All molars exhibited severe periodontitis and the decision
was rendered to extract them at this time, owing in part, to the
absence of bisphosphonate intake. General anaesthesia was
F I G U R E 2 Perioral eczema observed a few weeks after
hypersensitive reaction to nickel contained in prosthesis clasps
preferred because her general osteoarticular pain, joint pain
in the temporomandibular articulation and mouth opening
limitation made it difficult for the woman to lie down and
to keep her mouth open for a long time. Her daily treatment
was not modified for the surgery but antibiotics (amoxicillin
and clavulanic acid, 7 days) and mouthwashes (chlorhexidine
digluconate 0.12%, 10 days) were also prescribed. The patient
was happy to brush her teeth with a postsurgical toothbrush
and preferred fluid and soft food for a few days. To accustom
her to wearing the prosthesis, it was decided not to remove all
the teeth at first but to keep teeth 11, 12, 13, 22, 23, 31, 32,
33, 41, 42, and 43. Therefore, two RPDs were made, which
would be transformed into complete removable dentures later.
Unfortunately, 3 days after the placing of the first ele-
ments, the patient presented severe cutaneous reactions of the
face and throat and mucogingival erythema on the palatal
and vestibular gingiva under the devices (Figure 2). The
dermatology clinician's report (Toulouse Rangueil Hospi-
tal, Toulouse, France) described “a very oedematous peri-
oral eczema with throat diffusion.” An allergist examined
the patient and concluded on a “possible hypersensitivity
reaction.” The patch test performed revealed an exacerbated
nickel-sulphate response at 72 hours (Figure 3). The aller-
gist established a link between the cutaneous reaction and the
materials used to make the clasps of the prostheses (nickel,
iron, chromium, and molybdenum). Also, the laboratory's
prosthesis identification card confirmed that the metal was a
quaternary alloy (Figure 4).
The patient's daily treatment was modified by the addition
of sterile water and dermal corticoids to apply to the cutaneous
reaction. Then, the decision was taken in accordance with the
patient to cut all clasps and to speed up the care procedures,
which meant extracting the remaining teeth without giving
the patient the possibility of a testing period with the RPD.
A second general anaesthesia was not performed because the
woman's general health was less degraded at the time of the
second surgery and also because all teeth to be extracted were
mobile and located in the anterior sector, so it was not neces-
sary for her to open her mouth wide. Mouthwashes and advice
on food were again given to the patient.
F I G U R E 3 Cutaneous test report revealing the hypersensitivity reaction to nickel sulfate at 72 hours
F I G U R E 4 Extract from the identification card of the prosthesis,
confirming the presence of nickel in the composition
F I G U R E 5 Application of sterilized petroleum jelly body lotion
to skin irritations during dental care
In this patient, general osteoarticular pain complicated den-
tal care through the difficulties she experienced in staying in a
decubitus position and opening her mouth for a long time. She
also presented an articular pain crisis during a dental appoint-
ment, which made it necessary to interrupt tooth extractions
and wait for a few minutes. In addition, sterilized petroleum
jelly body lotion (Vaseline Stérilisée, Cooper, France) was
applied to skin irritations all around the oral cavity before
each dental appointment, to protect them from dehydration
and reduce care-related irritation (Figure 5).
Forced to stop work several years earlier and fully aware
of her state of health, the patient demonstrated extreme moti-
vation and cooperation for care. Despite a lack of healing of
the perioral and throat eczema due to her syndrome, she was
extremely patient and not emotional. The patient never missed
F I G U R E 6 Two complete removable prostheses were inserted
after tooth extractions
an appointment and she was satisfied with the aesthetic result,
fulfilling her initial motivation to seek care (Figures 6 and 7).
In addition, the patient began transition into a more normal
diet.
3 DISCUSSION
Although it could be expected that SAPHO is infrequently
encountered in dental practice,28 the attending clinician
should be familiar with management strategies for oral and
perioral allergic reactions.
The patient's demographic information in this case report
was consistent with some other epidemiological stud-
ies revealing a slight female predominance for SAPHO
syndrome1,3,29 and for nickel allergy.30 The patient devel-
oped a nickel allergy, which is found in 13% of the general
population.31 The literature on SAPHO syndrome includes
some reports concerning children2 but the syndrome is essen-
tially found in adults. Its aetiology and its physiopathological
mechanism are still unknown.14,32,33 A possible association
with HLA-B27 was initially suspected7 (as in spondylarthro-
sis) but recent studies have dismissed this hypothesis1,15,34
F I G U R E 7 Recall appointment 2 months after fitting of
prosthesis. Peri-oral and throat eczema still present and has not healed
yet due to skin healing difficulties in patients with SAPHO syndrome
given that only a minority of patients present the antigen. Thus
SAPHO syndrome may have a genetic or immune origin or
occur after a Propionibacterium Acnes infection.9 An antibi-
otic treatment targeting this bacterium has already shown
good results on patients’ health1,8 but disease progression
starts again when the treatment is stopped and not all the
patients respond well to the antibiotic.1 Thus, the etiopatho-
genesis of SAPHO syndrome may be multifactorial and not
solely regarded as an infectious process.
Nickel is one of the most common allergens used
in dental prostheses31 and hypersensitivity reactions may
develop 24-72 hours after contact with saliva. Manifes-
tations include perioral dermatitis, burning mouth syn-
drome, lichenoid reactions, cheilitis, gingivitis, and orofacial
granulomastosis.31,35,36
In the particular case of patients with SAPHO syndrome,
the main complications occur in presence of mandibular
osteomyelitis and bisphosphonate treatments but all other
symptoms of this syndrome must be considered before start-
ing any dental therapy. Because of the low incidence of this
syndrome, there are no clear recommendations for its oral
management. Nevertheless, it is possible to identify some
important principles applicable to dental care in general.
When articular pain occurs, modification of dental care may
be necessary, such as reducing the length of the patient's den-
tal appointment and their time maintaining an open mouth.
The complexity of these cases makes it essential to coor-
dinate medical and dental care. A multidisciplinary team
approach may be warranted within a hospital environment
and perhaps augmented with the services of a physiotherapist
when an affected patient experiences acute exacerbations.37
The onset of oral and perioral allergic reactions, such as nickel
(as seen in the featured case report) may further complicate
dental therapy. Moreover, the dentist may play integral role in
the diagnosis of SAPHO syndrome. In a recent case report,
mandibular pain, the first symptom reported, led to SAPHO
discovery.38 Elimination of any other dental cause of pain is
essential and, in the case in question, CBCT was performed,
revealing a sclerotic change and a periosteal reaction on the
affected side of the mandible.38
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